RenalytixAI
The firm's prognostic test uses biomarker testing and clinical information to generate a score indicating a patient's risk of developing kidney disease.
Renalytix Kidney Disease Test Gets FDA Clearance
The test, which assesses predictive blood-based biomarkers and electronic health record data, was first introduced in the US in late 2020 as a laboratory-developed test.
In Brief This Week: CAP, T2 Biosystems, Siemens Healthineers, DiaSorin, More
News items for the week of June 5, 2023.
In Brief This Week: SQI Diagnostics, Chembio, Accelerate, Seegene, Freenome, More
News items for the week of March 27, 2023.
In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More
News items for the week of Nov. 28, 2022.
Oct 31, 2022
Renalytix Posts $2.9M in Revenue for Fiscal 2022
Jul 1, 2022
360Dx Top 30 Drops 5 Percent in June
Dec 7, 2021
Renalytix Posts $482K in Fiscal Q1 Revenues
Oct 21, 2021